Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Initially approved for glycemic control in type 2 diabetes mellitus, their clinical application has expanded into obesity management, cardiovascular risk reduction, and metabolic syndrome modulation
Mann JFE, rsted DD, Brown-Frandsen K, LEADER Steering Committee and Investigators, et al
This is a multi-tasking treatment that aims to target and control your insulin level and blood pressure
If the FDA grants this designation (which it has not yet), Lilly would receive more intensive FDA guidance and a potentially faster review
US$ 28.46
US$ 22.93
US$ 21.69
US$ 22.24
